- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06521918
Combined Artificial Intelligence and Mobile Application for Remote Infant Motor Screening: Development and Validation
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Suh-Fang Jeng, Professor
- Phone Number: 886-2-33668132
- Email: jeng@ntu.edu.tw
Study Locations
-
-
-
Taipei, Taiwan, 100, Taiwan
- Recruiting
- National Taiwan University
-
Contact:
- Suh-Fang Jeng, Professor
- Phone Number: 886-2-33668132
- Email: jeng@ntu.edu.tw
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
This study will recruit preterm and term infants from National Taiwan University Children's Hospital (NTUCH), Taipei, Taiwan, with the former recruited from the neonatal follow-up clinic and the latter from the well-baby follow-up clinic.
Two pediatric physiotherapists providing early intervention to the participating infants will be invited to complete a feedback questionnaire about the APP "Baby Go."
Description
The inclusion criterion is:
Preterm infants: gestational age < 37 weeks, birth body weight < 2,500 grams, and corrected age of 2-18 months.
Term infants: gestational age 37-42 weeks, birth body weight >2,500 grams, and age of 2-18 months.
Clinicians: who provide early intervention to the participating infants in this study.
The exclusion criterion is:
Infants: parents can not read Chinese. Clinicians: can not read Chinese
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Term infants
The inclusion criterion is: gestational age 37-42 weeks, birth body weight >2,500 grams, and age at 2-18 months. The exclusion criterion is: parents can not read Chinese. |
|
Preterm infants
The inclusion criterion is: gestational age < 37 weeks, birth body weight < 2,500 grams, and corrected age of 2-18 months. The exclusion criterion is: parents can not read Chinese. |
|
Clinicians
The inclusion criterion is: who provide early intervention to the participating infants in this study. The exclusion criterion is: can not read Chinese |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alberta Infant Motor Scale (AIMS)
Time Frame: 3 - 18 months of age
|
motor function in supine, prone, sitting and standing position
|
3 - 18 months of age
|
|
Age of walking attainment
Time Frame: 9 - 18 months of age
|
Age of attaining independent walking for at least five steps
|
9 - 18 months of age
|
|
User experience from parents
Time Frame: When the infant approached 6 months, 12 months, and 18 months
|
Parents' perspectives on the use of the APP "Baby Go" were collected using Google Forms (For parents: https://forms.gle/BPL7CWopaB7qk3388).
The questionnaire for parents was customized for the APP "Baby Go" in this study and adapted from a survey used in the "Baby Moves" APP previously described by Kwong et al.
The questionnaire for the parents consisted of three sections: (1) frequency of the APP use, (2) benefits of the APP use, and (3) user's experience.
Questionnaires contained three types of measures: (1) multiple choice, (2) five-point Likert scale, and (3) open-ended questions.
|
When the infant approached 6 months, 12 months, and 18 months
|
|
User experience from clinicians
Time Frame: When the infant 18 months
|
Clinicians' perspectives on the use of the APP "Baby Go" were collected using Google Forms (for clinicians: https://forms.gle/3L7nGKe2ZTT39t7n6).
The questionnaire for clinicians is customized for the APP "Baby Go" in this study and adapted from a healthcare professional interview previously described by AlMahadin et al. 44 The questionnaire for clinicians contains two sections: (1) perspectives of the APP use and (2) recommendations of APP use.
Each questionnaire contains three types of measures: (1) multiple choice, (2) five-point Likert scale, and (3) open-ended questions.
|
When the infant 18 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Suh-Fang Jeng, Professor, School and Graduate Institute of Physical Therapy, National Taiwan University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 202311095RIND
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.